Funding

SECTION I: ESTIMATION OF COSTS

1

Taking into account the rest of the cost evaluation please provide an overall estimation of the total costs for full deployment/production of the R & D result.
… in terms of IPR protection
Minimum spending of 2.000,00 € / year for the safety of the workplace and employees.
…in terms of product development
€ 25,000.00 would be needed for further development of the material including the analysis and testing to become more competitive at European level.
…in terms of mass production
€ 250,000.00 in a 60% to put into production and 40% for management costs
… in terms of marketing
A minimum of € 5,000.00 / year since the product will be sold on the open market, which requires a wide coverage to get the necessary visibility of the product.

 

2

Based on the above assessment as well as the marketing information please provide the correct estimation of the price for R&D product in correlation with costs

Year 1

Year 2

Year 3

Year 4

Year 5

Fixed costs

2.000,00€

2.000,00€

2.000,00€

2.000,00€

2.000,00€

Personnel

140.000,00€

142.000,00€

145.000,00€

147.000,00€

150.000,00€

Other running costs

160.000,00€

120.000,00€

95.000,00€

88.000,00€

76.000,00€

Marketing costs

5.000,00€

5.000,00€

5.000,00€

5.000,00€

5.000,00€

TOTAL EXPECTED COSTS

307.000,00€

269.000,00€

247.000,00€

242.000,00€

233.000,00€

Price per Unit

Type of Unit

Number of Units

TOTAL Expected Revenues

570.000,00€

520.000,00€

480.000,00€

430.000,00€

400.000,00€

CASH FLOW REQUIRED (REVENUES-COSTS)

200.000,00€

251.000,00€

233.000,00€

188.000,00€

167.000,00€

TOTAL CAPITAL required for five years

150.00,00€

 

SECTION 2: QUALITATIVE FACTORS

4

Dimension of identified target groups
An estimation of the proportion of the target market (described in Section 3) which we expect to take
99% manufacturers of ceramic sanitary fixtures, 1% private operators.

6

Evaluation of financial Risks for R&D result
The major financial risks may come from the competition by placing on the market a similar product with the same specifications or better and sold at a cheaper price, the expected decrease in the business plan with consequent reduction of the same.

SECTION 3: IDENTIFICATION OF FINANCING SOURCES

  1. 1.  European Funding

Define relevance of the product with the following potential funding sources and comment

1.

2.

3.

2. National Funding

1.

2.

3.

3. Private funding

1.

2.

3.

4. Other

1.

2.

3.

SECTION 3: FINAL EVALUATION

It is requested a final evaluation considering the funding opportunities you believe most suitable for the exploitation of the R&D result, considering the possibility of the creation of a spin-off, further research, in particular, a cost/benefit analysis and a financial projection for the R&D result, type of collaboration identified (i.e. Licensing Agreement, Technical Cooperation, Joint Venture, Manufacturing Agreement, Commercial Agreement with Technical Assistance, Creation of a spin-off, Joint further development)…
The project probably will be financed through private funds or rotation with any State grants or Bank loans that would reduce the financial risk.

Decision of evaluation (Please tick  as appropriate)

The R&D has a high potential of exploitation

The R&D result needs minor revisions

X

The R&D result needs moderate revisions

The R&D result needs major revisions

The R&D result has no potential of exploitation

Bookmark the permalink. Follow any comments here with the RSS feed for this post. Post a comment or leave a trackback: Trackback URL.

Post a Comment

You must be logged in to post a comment.

Request a proposal

Valorisation Plan Authors

Related Documents

There in no related documents

Visit the other applications of the INTERVALUE Platform: R&D Repository | IP Agreements

© 2009-2010 INTERVALUE Project